VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2017.10.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Phase Iiib Study of Lenalidomide Plus Rituximab Followed by Maintenance in Relapsed or Refractory Nhl: Analysis of Marginal Zone Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Rituximab Maintenance After Nordic Protocol (R-Maxichop/Hd-Arac/Asct) Significantly Prolongs Survival in Young Mantle Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Evolution of Clonal Hematopoiesis in Mantle Cell Lymphoma Patients Before, During, and After Induction Chemotherapy and Autologous Stem Cell Transplantation

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Rituximab and FAB/LMB 96 Chemotherapy in Children With Stage III/IV B-Cell Non-Hodgkin Lymphoma: A Children’s Oncology Group Report

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Prospective Clinical Study of R-CMD Therapy for Indolent B Cell Lymphoma and Mantle Cell Lymphoma From the Hokuriku Hematology Oncology Study Group

Medical Oncology
MedicineCancer ResearchOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy